Filip Janku
Chief Medical Officer at Monte Rosa Therapeutics, Inc. (GLUE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 5,40760,612 held (−8%) | $24.50 | $132K | -58.0% |
| Jun 30SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 6,00059,992 held (−9%) | $22.95 | $138K | -55.1% |
| Jun 25SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 11,84559,992 held (−16%) | $20.22 | $240K | -49.1% |
| Jun 25SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 30,00059,992 held (−33%) | $21.42 | $643K | -51.9% |
| Feb 24SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 9,18965,837 held (−12%) | $19.50 | $179K | -47.2% |
| Jan 5SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 3,15575,026 held (−4%) | $15.17 | $48K | -32.1% |
- Sell
Chief Medical Officer Filip Janku sold $132K of GLUE at $24.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Filip Janku sold $138K of GLUE at $22.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Filip Janku sold $240K of GLUE at $20.22 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Filip Janku sold $643K of GLUE at $21.42 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.